The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Endoscopic monitoring of Crohn's disease treatment: A prospective, randomized clinical trial
Abstract
A randomized clinical trial was conducted to determine whether colonoscopy is useful in deciding how long to maintain steroid treatment in attacks of Crohn's disease involving the colon. One hundred forty-seven patients with acute attacks of colonic or ileocolonic Crohn's disease were treated by oral prednisolone, 1 mg.kg-1.day-1; 136 achieved clinical remission, but 96 of them still had active endoscopic lesions and were randomized either to immediate start of steroid tapering (group A; n = 46) or to continued prednisolone treatment at the same dosage for 5 more weeks before steroid tapering was begun (group B; n = 50). In the remaining 40 patients (already in endoscopic remission, group C), steroid tapering was begun immediately. After prednisolone discontinuation, patients were followed up for 18 months or until clinical relapse. Prolongation of prednisolone therapy significantly improved the endoscopic scores in group B (30% of endoscopic remission). The frequency of successful steroid weaning was almost identical in groups A and B (82% and 80%, respectively), as was the actuarially calculated relapse clinical rate after steroid withdrawal (P = 0.22). No factor predictive of clinical relapse could be found. The clinical course of patients in group C was similar to that of those in groups A and B. Overall, only 22% of the 147 patients were still in clinical remission and off steroids 18 months after prednisolone discontinuation, outlining the need for maintenance therapy. In conclusion, for patients who have achieved clinical remission, adjustment of steroid treatment duration on the basis of endoscopy results is of no benefit, and the endoscopic aspect has no prognostic value; thus, it appears unnecessary to repeat colonoscopy in such patients before steroid tapering is begun.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The GETAID group has repeatedly shown that endoscopic activity of Crohn's disease correlates either poorly or not at all with a clinical disease activity index 6, 7, 29 .”
From The Manitoba IBD Index: Evidence for a New and Simple Indicator of IBD Activity (2009) · cites this paper as [7]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Nonparametric Statistics for the Behavioral Sciences.
Whitfield, J. W., & Siegel, S. (1957) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2342828 · Cited by 8,017
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,516
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,269
Breslow, N. E., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,381
Non-Parametric Statistics for the Behavioral Sciences.
Stuart, A., & Siegel, S. (1957) · Economica · doi:10.2307/2551606 · Cited by 3,403
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. I. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,814
Research works printed but not linked: 1
- Bernades, 1978, Proposition d'un système de critères pour le diagnostic des entérocolites inflammatoires (maladie de Crohn et rectocolite hémorragique). Une étude coopérative du GREC, Gastroenterol Clin Biol, 2, 1047
Cited by
Sorted by citations
Items 201–261 of 261
Mucosal healing in Crohn's disease: relevance and controversies in real life clinical practice.
González‐Lama, Y., Suárez, C. J., Blázquez, I., Calvo, M., Matallana, V., Vera, I., & Abreu, L. E. (2014) · PubMed · Cited by 2
Trends in Inflammatory Bowel Disease Therapy: A Meta-Analytic Approach
Whiting, G. W., Lau, J., Kupelnick, B., & Chalmers, T. C. (1995) · Canadian Journal of Gastroenterology · doi:10.1155/1995/283251 · Cited by 2
Niv, Y., Ilani, S., Levi, Z., Hershkowitz, M., O'Morain, C. A., O’Donnell, S., Scapa, E., Eliakim, R., Kalantzis, N., Fireman, Z., et al. (2011) · Gastroenterology · doi:10.1016/s0016-5085(11)63186-7 · Cited by 2
Hyun, H. K., Yu, J., Kang, E. A., Park, J., Park, S. J., Park, J. J., Kim, T. I., Kim, W. H., & Cheon, J. H. (2021) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.233 · Cited by 2
“However, there is a poor correlation between symptom scores and the degree of endoscopic inflammation as well as between clinical remission and mucosal healing [4].”
Lee, S. D., Clark‐Snustad, K., & Fisher, J. (2015) · Springer eBooks · doi:10.1007/978-3-319-14181-7_7 · Cited by 2
Han, W., Hu, J., Wu, J., Zhang, P., Liu, Q., Hu, N., & Mei, Q. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231224842 · Cited by 2
“14,19 Our results also indicated that the CDAI score and CRP level did not fully reflect the severity of endoscopic lesions.”
BackgroundNuclear Medicine in Pediatric Gastrointestinal Diseases
Cistaro, A., & Massollo, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-21371-2_9 · Cited by 2
Does Endoscopic Assessment of Mucosal Healing Affect IBD Management?
Keyashian, K. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3311-3 · Cited by 2
“An early randomized clinical trial published by the GETAID group provided no data to support the value of colonoscopy in deciding the length of steroid treatment in colonic CD [3].”
BackgroundKlinik, CRP, Calprotectin, MRT oder Endoskopie?
Prager, M., & Büning, C. (2014) · coloproctology · doi:10.1007/s00053-014-0464-7 · Cited by 1
Was ist gesichert in der Therapie chronisch entzündlicher Darmerkrankungen?
Siegmund, B., Preiß, J., & Zeitz, M. (2010) · Der Internist · doi:10.1007/s00108-010-2719-x · Cited by 1
Taking Crohn's Disease Personally
Chowers, Y. (2013) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10111 · Cited by 1
Standards of medical treatment and nutrition in Crohn’s disease
Siegmund, B., & Zeitz, M. (2004) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-004-0498-3 · Cited by 1
“However, there is controversy as to whether one should start with a maximum concentration of 60 mg prednisone/day compared with 1 mg prednisone/kg body weight per day [9, 10] (Fig.”
BackgroundKlinik, CRP, Calprotectin, MRT oder Endoskopie?
Prager, M., & Büning, C. (2013) · Die Gastroenterologie · doi:10.1007/s11377-012-0723-5 · Cited by 1
Construction of gene subgroups of Crohn disease based on transcriptome data
Ma, J., Zhang, H., Zhang, Y., & Wang, G. (2023) · Medicine · doi:10.1097/md.0000000000034482 · Cited by 1
“Endoscopy is an important tool for disease or treatment effect evaluation, and many ongoing biological agent trials require endoscopic evaluation.[19] SES-CD was developed as a simple and rapid CD endoscopic scoring system and was verified in the present study[20]; the higher the SES-CD, the more severe the condition.”
MethodDisease Modification in Inflammatory Bowel Disease
Hanauer, S. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.06.011 · Cited by 1
The IBD outpatient care in the clinical practice
Hrdlička, L. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.089 · Cited by 1
Apport de l'endoscopie dans la maladie de Crohn
Dewit, O., Fiasse, R., & Vanheuverzwyn, R. (2003) · Acta Endoscopica · doi:10.1007/bf03028414 · Cited by 1
“I1 n'y a cependant pas de correlation entre l'activitE clinique EvaluEe par le << Crohn's Disease Activity Index,> (CDAI), les paramEtres biologiques, le pronostic et cet index endoscopique [4].”
BackgroundMethodEnfermedad inflamatoria intestinal: reflexiones
Gassull, M. À. (2015) · Enfermedad Inflamatoria Intestinal al Día · doi:10.1016/j.eii.2015.04.001 · Cited by 1
Traitement de la maladie de Crohn de l'adulte
Bellanger, J., Cosnes, J., Jp, G., Beaugerie, L., Malafosse, M., & Quintrec, Y. L. (1994) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(05)82184-8 · Cited by 1
Schlup, M., Chang, A. R., Chadwick, D., Ferry, D. M., & CHADWICK, V. S. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098300 · Cited by 1
Abreu, A. C., Damião, A. O. M. C., da Silva, A. N., Fachin, A. V., Prudente, C. L., Machado, A. D., Westphalen, A. P., Vieira, A., Paula, A., Malheiros, R. S., et al. (2010) · Cited by 1
Gangaidzo, I. T., & Gordeuk, V. R. (1996) · Gut · doi:10.1136/gut.38.6.937-a · Cited by 1
Outcomes, Disease Activity Indices and Study Design
Osterman, M. T., Lewis, J. D., & Aberra, F. N. (2010) · doi:10.1002/9781444318418.ch23
Mucosal Healing in IBD: Does it Matter?
D’Haens, G. (2011) · doi:10.1002/9781444342574.ch44
The Role of Endoscopy in Diagnosis and Treatment of Inflammatory Bowel Disease
Dai, S.-C., & Lo, S. K. (2010) · Wiley eBooks · doi:10.1002/9781444318418.ch18
Medikamentöse Therapie des Morbus Crohn
Adler, G. (1996) · Springer eBooks · doi:10.1007/978-3-642-61023-3_17
Noninvasive monitoring of activity in Crohn's disease
Sipponen, T. M. (2009) · Työväentutkimus Vuosikirja
The Use of Endoscopy to Follow the Clinical Course of Crohn’s Disease
Samaan, M., & D’Haens, G. (2014) · Springer eBooks · doi:10.1007/978-3-319-11077-6_14
Quand faut-il refaire une endoscopie au cours des maladies inflammatoires chroniques de l’intestin?
Hébuterne, X. (1997) · Acta Endoscopica · doi:10.1007/bf02968693
“Le nombre de patients corticod6pendants 6tait finalement identique dans les deux groupes, et apr6s un suivi de 18 mois, le nombre de rechutes n'avait pas 6t6 modifi6 par la poursuite du traitement par prednisolone sur la seule indication de la prdsence de 16sion endoscopique [2].”
BackgroundEderle, A., Inturri, P., Brosolo, P., Fantin, A., & Preto, M. (2006) · Springer eBooks · doi:10.1007/88-470-0434-9_9
Place de l’endoscopie dans le choix thérapeutique au cours des MICI
Cortot, A. (1997) · Acta Endoscopica · doi:10.1007/bf02968691
Self-citationSection editors' commentary. Usefulness of Crohn's disease activity index in medicine
Banks, P. A., & Present, D. H. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780050213
Surveillance d’une maladie de Crohn: quand?, comment?, pourquoi?
Bélaïche, J. (1997) · Acta Endoscopica · doi:10.1007/bf02963624
Campieri, M., Rizzello, F., & Gionchetti, P. (2008) · Digestive and Liver Disease Supplements · doi:10.1016/s1594-5804(08)60014-5
Blonski, W. C., & Lichtenstein, G. R. (2006) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2005.10.036
La maladie de Crohn corticodépendante
Lerebours, É., & Savoye, G. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)95004-x
“La prolongation du traitement, pour tenter d’obtenir une cicatrisation endoscopique des lésions, ne s’accompagne pas d’une réduction de l’incidence de la corticodépendance (20 % versus 18 %) [3].”
BackgroundFlorie, J. (2007) · UvA-DARE (University of Amsterdam)
Miheller, P., Mandel, M. D., Müllner, K., & Lakatos, P. L. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.824675
Endoscopic stenting in gastrointestinal tract
Keränen, I. (2013) · Työväentutkimus Vuosikirja
Les scores endoscopiques des MICI
Bouhnik, Y., Attar, A., & Tréton, X. (2009) · Côlon & Rectum · doi:10.1007/s11725-009-0151-y
Alberini, J., Charron, M., Markowitz, J. E., von Allmen, D., & Hurh, P. J. (2003) · 核子醫學雜誌 · doi:10.6332/anms.1601.001
“Extent and severity of the disease cannot be evaluated with reliability by colonoscopic findings [2-5].”
BackgroundAktuelle Therapie der Colitis ulcerosa
Schoepfer, A., & Seibold, F. (2006) · BORIS (University Library Bern)
Usefulness of Crohnʼs Disease Activity Index in Medicine
Banks, P. A., & Present, D. H. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199905000-00012
Treatment of Crohn's Disease by Lymphocyte A Randomized Controlled Trial Apheresis:
Lerebours, É., BUSSEL, A., Modigliani, R., Bastit, D., Florent, C., Rabian, C., René, E., & Soulc, J.-C. (1994)
Self-citationEndoscopic monitoring in inflammatory bowel diseases: in whom, when, and how?
Tezel, A. (2010) · DergiPark (Istanbul University)
Approach to the Patient with Inflammatory Bowel Disease
Kühbacher, T., & Schreiber, S. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3402-5.50015-0
Objective Assessment of Clinical Disease Activity
Louis, E. J., Kemseke, C. V., & Reenaers, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-33703-6_23
Medical therapy of steroid-resistant
Sands, B. E. (2000)
Medikamentöse Therapie des Morbus Crohn
Hoffmann, J. (2020) · Springer eBooks · doi:10.1007/978-3-662-59104-8_16
Surgery and stomas in Crohn's disease
Kalman, T. D. (2021) · Linköping University medical dissertations · doi:10.3384/diss.diva-172781
Medical therapy for Crohn’s disease
Hanauer, S. B., & Dassopoulos, T. (2003) · Springer eBooks · doi:10.1007/978-1-4020-3477-0_33
CROHN'S DISEASE: AETIOLOGY, PATHOLOGY, DIAGNOSIS AND MEDICAL TREATMENT
(2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-2723-9.50047-6
Medikamentöse Therapie des Morbus Crohn
Adler, G. (1993) · Springer eBooks · doi:10.1007/978-3-642-97440-3_17
Importance of mucosal healing in Crohn’s disease and ulcerative colitis
D’Haens, G. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5889-9_14
How do I use steroids in Crohn’s disease?
Schölmerich, J. (2007) · Springer eBooks · doi:10.1007/1-4020-4316-3_13
Brzezinski, A., & Lashner, B. A. (1999) · Springer eBooks · doi:10.1007/978-1-4612-1396-3_5
Pray, C., Wong, E. C. L., Aruljothy, A., Dulai, P. S., Marshall, J. K., Reinisch, W., & Narula, N. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac210
Régulation de la douleur inflammatoire viscérale par les opioïdes d’origine lymphocytaire
Mas‐Orea, X., Maurel, S., & Dietrich, G. (2022) · Douleur et Analgésie · doi:10.3166/dea-2022-0223
Food intolerance testing and dietary manipulation in inflammatory bowel disease
Inns, S. J. (2011) · UCL Discovery (University College London)
Activity Indices-Based Assessment of Disease Activity in Inflammatory Bowel Disease
Louis, E. J., Kemseke, C. V., & Reenaers, C. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0998-4_23
“has long been considered as the only relevant end point of treatments [ 4, 5 ] .”
BackgroundRôle des opioïdes d'origine immunitaire dans la physiologie intestinale
Mas‐Orea, X. (2023) · theses.fr (ABES) · doi:10.70675/6cd99022zee97z4fb8z88b8ze33376897272
Metadata
- Authors
- Landi, B., Anh, T. N., Cortot, A., Soule, J. C., Rene, E., Gendre, J. P., Bories, P., See, A., Metman, E. H., Florent, C., Lerebours, E., Mary, J. Y., & Modigliani, R.
- Affiliations
- Inserm (FR)
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 1992-05
- Volume
- 102
- Issue
- 5
- Pages
- 1647-1653
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1876519312
- Cited by
- 261
- References
- 26
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 13 · 2014: 13 · 2013: 16 · 2012: 10
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- Crohn's disease, colonoscopy, endoscopic surveillance, prednisolone, corticosteroid tapering, corticosteroid withdrawal, endoscopic remission, clinical relapse, maintenance therapy, colonic Crohn's disease, ileocolonic Crohn's disease
- MeSH terms
- Adult, Colonoscopy, Crohn Disease, Female, Follow-Up Studies, Humans, Male, Prednisolone, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
